Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Alnylam Pharmaceuticals, Inc.    ALNY   US02043Q1076

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/23/2015 02/24/2015 02/25/2015 02/26/2015 02/27/2015 Date
104.1(c) 105.23(c) 106.66(c) 104.39(c) 102.5337 Last
753 039 600 976 701 236 403 086 52 230 Volume
+1.67% +1.09% +1.36% -2.13% -1.78% Change
More quotes
Company
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company, which develops novel therapeutics based on RNA interference.It is leading the translation of RNAi as a new class of innovative medicines with a core focus on RNAi therapeutics for the treatment of genetically defined diseases, including... 
Sector
Biotechnology & Medical Research
Calendar
03/04 | 10:00amPresentation
More about the company
Surperformance© ratings of Alnylam Pharmaceuticals, I
Trading Rating : Investor Rating :
More Ratings
Chart ALNYLAM PHARMACEUTICALS, I
Duration : Period :
Alnylam Pharmaceuticals, I Technical Analysis Chart | ALNY | US02043Q1076 | 4-Traders
Full-screen chart
Financials ($)
Sales 2015 56,7 M
EBIT 2015 -241 M
Net income 2015 -236 M
Finance 2015 808 M
Yield 2015 -
Sales 2016 62,6 M
EBIT 2016 -262 M
Net income 2016 -268 M
Finance 2016 639 M
Yield 2016 -
PER 2015 -
PER 2016
EV / Sales 2015 140x
EV / Sales 2016 129x
Capitalization 8 744 M
More Financials
Latest news on ALNYLAM PHARMACEUTICALS, I
02/25 ALNYLAM PHARMACEUTICALS : to Webcast Presentation at Cowen & Company 35th Annual..
02/24 ALNYLAM PHARMACEUTICALS : to Present at 2015 RBC Capital Markets' Global Healthc..
02/23 ALNYLAM PHARMACEUTICALS : Schedules Presentation at 2015 RBC Capital Markets' Gl..
02/21 Alnylam Pharmaceuticals Recaps Fourth Quarter and Full Year 2014 Financial Re..
02/19 Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2014 Financial R..
02/18 ALNYLAM PHARMACEUTICALS : to Webcast Presentation at 2015 RBC Capital Markets' G..
02/18 ALNYLAM PHARMACEUTICALS : to Webcast Presentation at 2015 RBC Capital Markets&rs..
02/17 Alnylam Pharmaceuticals Posts Fourth Quarter and Full Year 2014 Financial Res..
More news
Sector news Biotechnology & Medical Research - NEC
09:44a ISIS PHARMACEUTICALS : Reports Positive Phase 1 Data Demonstrating ISIS-PKK Rx P..
09:31a ISIS PHARMACEUTICALS : Reports Financial Results and Highlights for 2014
08:01a QUINTILES TRANSNATIONAL : CEO to Present at Barclays Global Healthcare Conferenc..
Plus d'actualités du secteur Biotechnology & Medical Research - NEC


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF